Government prohibits 328 fixed dose combinations
The health ministry pruned a list of banned combination medicines and added restrictions to the dosages or uses for six more types of such drugs, saying their ingredients had no…
U.S. appeals court invalidates Acorda patents on MS drug
By Jan Wolfe A U.S. appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door for generic competition for Acorda’s flagship product.…
Orexo soars after winning opioid drug appeal against Teva
By Jonathan Stempel A U.S. appeals court on Monday revived Swedish pharmaceutical company Orexo AB’s lawsuit accusing a unit of Israel’s Teva Pharmaceutical Industries Ltd of infringing a patent for…
Glenmark Pharma arm gets nod for generic version of asthma drug in Germany
New Delhi: Glenmark Pharma’s subsidiary has secured marketing authorisation in Germany for generic version of GlaxoSmithKline’s Seretide Accuhaler, used to treat asthma. “Fluticasone/Salmeterol DPI is a combination product for the…
GSK Pharma in search of buyer for non-core brands
MUMBAI: British drug maker GSK Pharma’s India arm is looking to sell some of its non-core brands as the company looks to consolidate its position in the chronic and vaccine…
Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer
Mumbai: Pharma major Pfizer fears that the pharma industry is expected to face challenges from price controls, ad-hoc regulatory changes and new policies that may impact sustainable growth. “Even though…
Pharma unit owner among 6 held
Phagwara: Owner of a pharmaceutical unit has been arrested for not having proper bills for the raw material for manufacturing psychotropic drugs. The premises of Long Life Pharmaceuticals was raided…
Domestic pharma players eye Bharat Serums acquisition
MUMBAI: Domestic pharmaceutical companies Cipla, Zydus Cadilla, Dr Reddy’s Laboratories and private equity fund Baring Asia are among those evaluating the acquisition of Mumbai-based vaccine maker Bharat Serums and Vaccines…
J&J may have to compensate for faulty hip implants
The health ministry is reaching out to states following recommendations by an expert committee to compensate Indian patients who experienced adverse effects from hip implants imported and sold by Johnson…
Pharma stocks in good health; Divi’s Labs, Lupin jump up to 3%
NEW DELHI: Gains in shares of Divi’s Laboratories (up 2.94 per cent), Lupin (up 2.30 per cent) and Cadila Healthcare (up 1.79 per cent) lifted Nifty Pharma index up in…
